MyTomorrows
This article needs additional citations for verification. (January 2019) |
Company type | Naamloze Vennootschap |
|---|---|
| Industry | Healthcare, Pharmaceuticals |
| Founded | 2012[1] |
| Headquarters | , |
Key people | Ronald Brus (CEO), Ronald Plasterk (CSO) |
| Products | Experimental drugs |
| Website | mytomorrows.com |
myTomorrows is the trade name of Impatients N.V., a globally active healthcare company.[2] The company is based in the Zuidas, Amsterdam, Netherlands. myTomorrows provides patients with unmet medical needs, and their doctors, information about treatment options worldwide and facilitates access to medicines in development.[3][4] Access to these medicines can be achieved via clinical trials, expanded access and off-label use.
myTomorrows was founded in 2012 by Ronald Brus, former CEO of the biotechnology company Crucell.[1] In the beginning of its existence, myTomorrows has been characterized as innovative and controversial.[5] In May 2013, MP Lea Bouwmeester asked parliamentary question about the company.[5] In December 2017, former minister Ronald Plasterk joined the company as Chief Scientific Officer.[6]
References
- ^ a b "Dutch life science startup offers access to late-stage drugs for patients with few options". MedCity News. 2014-02-20. Retrieved 20 November 2018.
- ^ "MyTomorrows, dernière chance pour des patients". Le Monde. Retrieved 21 November 2018.
- ^ "myTomorrows raises further 10M to help access drugs in development". TechCrunch. Retrieved 20 November 2018.
- ^ "Patients' Right To Try Should Not Be A License To Fleece Them". Forbes. Retrieved 8 January 2019.
- ^ a b "myTomorrows is de Uber van de medicijnen". NRC Handelsblad. Retrieved 21 November 2018.
- ^ "Plasterk gaat naar farmabedrijf Mytomorrows". NU.nl. Retrieved 21 November 2018.
External links
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.